Indication
Walking impairment due to multiple sclerosis
Walking impairment due to multiple sclerosis is a prominent neurological mobility deficit affecting individuals with multiple sclerosis, an autoimmune demyelinating and neurodegenerative disorder of the central nervous system. Read more about Walking impairment due to multiple sclerosis
12 drugs 11 manufacturers
Drugs that treat it
Common Walking impairment due to multiple sclerosis therapies.
DALFAMPRIDINE ER (dalfampridine)
DALFAMPRIDINE ER (dalfampridine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonWalking impairment due to multiple sclerosis is a prominent neurological mobility deficit affecting individuals with multiple sclerosis, an autoimmune demyelinating and neurodegenerative disorder of the central nervous system.
It arises from immune-mediated inflammatory demyelination and axonal transection across motor, sensory, and cerebellar pathways, disrupting signal conduction between the brain, spinal cord, and peripheral musculature.
Clinically, the condition manifests as reduced gait speed, shortened stride length, prolonged double-support time, and decreased walking endurance, frequently compounded by lower-extremity spasticity, paresis, sensory ataxia, and fatigue.
As a progressive functional complication, it severely compromises independent ambulation and serves as a key benchmark of advancing physical disability in this patient population.
- govdelivery.com
Walking impairment due to multiple sclerosis is a prominent neurological mobility deficit affecting individuals with multiple sclerosis, an autoimmune demyelinating and neurodegenerative disorder of the central nervous system It arises from immune-mediated inflammatory demyelination and axonal transection across motor, sensory, and cerebellar pathways, disrupting signal conduction between the brain, spinal cord, and peripheral musculature
- nih.gov
Walking impairment due to multiple sclerosis is a prominent neurological mobility deficit affecting individuals with multiple sclerosis, an autoimmune demyelinating and neurodegenerative disorder of the central nervous system Clinically, the condition manifests as reduced gait speed, shortened stride length, prolonged double-support time, and decreased walking endurance, frequently compounded by lower-extremity spasticity, paresis, sensory ataxia, and fatigue
- nationalmssociety.org
It arises from immune-mediated inflammatory demyelination and axonal transection across motor, sensory, and cerebellar pathways, disrupting signal conduction between the brain, spinal cord, and peripheral musculature
- nationalmssociety.org
It arises from immune-mediated inflammatory demyelination and axonal transection across motor, sensory, and cerebellar pathways, disrupting signal conduction between the brain, spinal cord, and peripheral musculature Clinically, the condition manifests as reduced gait speed, shortened stride length, prolonged double-support time, and decreased walking endurance, frequently compounded by lower-extremity spasticity, paresis, sensory ataxia, and fatigue
- nih.gov
Clinically, the condition manifests as reduced gait speed, shortened stride length, prolonged double-support time, and decreased walking endurance, frequently compounded by lower-extremity spasticity, paresis, sensory ataxia, and fatigue
- nih.gov
Clinically, the condition manifests as reduced gait speed, shortened stride length, prolonged double-support time, and decreased walking endurance, frequently compounded by lower-extremity spasticity, paresis, sensory ataxia, and fatigue
- fda.gov
As a progressive functional complication, it severely compromises independent ambulation and serves as a key benchmark of advancing physical disability in this patient population
- nih.gov
As a progressive functional complication, it severely compromises independent ambulation and serves as a key benchmark of advancing physical disability in this patient population
Personalize your experience
Follow Walking impairment due to multiple sclerosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.